Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/15 16:05 | 10/27/15 | MMMS | Health | Biolab | Testing Laboratories | Diamantis Christopher Eric | FL | D | P.d | 100 | 1.00 | 0 | 100 | 0 | D | ||||||||||||||||
8/12/15 10:54 | 6/30/15 | MMMS | Health | Biolab | Testing Laboratories | Sainsbury Sebastien | FL | D | P | 800 | 4.00 | 0 | 200 | New | 200 | I | |||||||||||||||
7/1/15 16:32 | 6/29/15 | MMMS | Health | Biolab | Testing Laboratories | Lagan Seamus | FL | DOT | CEO | M.d | 2,500 | 2.50 | 0 | 1,000 | 999% | 1,030 | I | ||||||||||||||
6/1/15 17:37 | 5/5/15 | MMMS | Health | Biolab | Testing Laboratories | Epizon, Ltd. | C5 | T | S | -4,800 | 4.00 | 0 | -1,200 | -21 | 4,600 | D | |||||||||||||||
6/1/15 17:36 | 5/5/15 | MMMS | Health | Biolab | Testing Laboratories | Diamantis Christopher Eric | FL | D | P | 2,700 | 3.60 | 0 | 750 | New | 750 | D | |||||||||||||||
7/11/13 14:18 | 10/1/12 | MMMS | Health | Biolab | Testing Laboratories | Simmons Jace | FL | OT | CFO | P.d | 0 | 0.00 | 0 | 1,000 | New | 1,000 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |